These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1175514)

  • 1. Reversal by vasotocin of pinealectomy and constant light effects on the pituitary melanocyte-stimulating hormone (MSH) content in the mouse.
    Pavel S; Gheorghiu C; Calb M; Petrescu M
    Endocrinology; 1975 Sep; 97(3):674-6. PubMed ID: 1175514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasotocin as a pineal hormone.
    Pavel S
    J Neural Transm Suppl; 1978; (13):135-55. PubMed ID: 224141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal by arginine-vasotocin of the effects of pinealectomy on the amount of 5-hydroxytryptamine in the hypothalamus and the concentrations of luteinizing hormone and follicle-stimulating hormone in the plasma of immature male rats.
    Pavel S; Luca N; Calb M; Goldstein R
    J Endocrinol; 1980 Jan; 84(1):159-61. PubMed ID: 7359076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pineal vasotocin: release into cat cerebrospinal fluid by melanocyte-stimulating hormone release-inhibiting factor.
    Pavel S; Goldstein R; Gheorghiu C; Calb M
    Science; 1977 Jul; 197(4299):178-9. PubMed ID: 17916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-wave sleep induced in cats by extremely small amounts of synthetic and pineal vasotocin injected into the third ventricle of the brain.
    Pavel S; Psatta D; Goldstein R
    Brain Res Bull; 1977; 2(4):251-4. PubMed ID: 912437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diel variations in arginine vasotocin content of goldfish brain and pituitary: effects of photoperiod and pinealectomy.
    Hontela A; Lederis K
    Gen Comp Endocrinol; 1985 Mar; 57(3):397-404. PubMed ID: 4039278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-melanocyte-stimulating hormone and [8-arginine]-vasotocin upon melanogenesis in hair follicle melanocytes in vitro.
    Logan A; Weatherhead B
    J Endocrinol; 1981 Dec; 91(3):501-7. PubMed ID: 6276486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine-vasotocin (AVT)--a pineal hormone in mammals.
    Goldstein R
    Rom J Endocrinol; 1992; 30(1-2):21-44. PubMed ID: 1305517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the effects of pinealectomy on the pituitary prolactin content in mice by very low concentrations of vasotocin injected into the third cerebral ventricle.
    Pavel S; Calb M; Georgescu M
    J Endocrinol; 1975 Aug; 66(2):289-90. PubMed ID: 1165458
    [No Abstract]   [Full Text] [Related]  

  • 10. A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1975; 17(4):296-308. PubMed ID: 1079927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of subcutaneous injections of melatonin, arginine vasotocin, and related peptides on pituitary and plasma levels of luteinizing hormone, follicle-stimulating hormone, and prolactin in castrated adult male rats.
    Vaughan MK; Blask DE; Johnson LY; Reiter RJ
    Endocrinology; 1979 Jan; 104(1):212-7. PubMed ID: 446349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pineal vasotocin: release into cat cerebrospinal fluid by melanocyte-stimulating hormone release-inhibiting factor.
    Pavel S; Goldstein R; Gheorghiu C; Calb M
    Science; 1977 Jul; 197(4299):179-80. PubMed ID: 17834087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oxytocin, vasotocin and alpha-MSH on renal function in the nonhuman primate.
    Wesley CR; Gilmore JP
    Horm Res; 1985; 21(1):55-9. PubMed ID: 3972337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pineal does not concentrate arginine vasotocin from biological fluids in vivo.
    Fisher LA; Schlosberg AJ; Fernstrom JD
    Endocr Res Commun; 1981; 8(2):135-44. PubMed ID: 7297478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I.
    Kastin AJ; Schally AV; Kostrzewa RM
    Fed Proc; 1980 Sep; 39(11):2931-6. PubMed ID: 6105977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in plasma corticosterone release in undisturbed chickens (Gallus gallus) in response to arginine vasotocin and corticotropin releasing hormone.
    Madison FN; Jurkevich A; Kuenzel WJ
    Gen Comp Endocrinol; 2008 Feb; 155(3):566-73. PubMed ID: 17936761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of peripherally injected pituitary peptides on recognition memory in pigeons.
    Sahgal A
    Regul Pept; 1986 Jul; 14(4):323-31. PubMed ID: 3018846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some questions related to melanocyte-stimulating hormone.
    Kastin AJ; Sandman CA; Miller LH; Schally AV
    Mayo Clin Proc; 1976 Oct; 51(10):632-6. PubMed ID: 966814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSH activity in plasma and pituitaries of rats after various treatments.
    Kastin AJ; Schally AV; Viosca S; Miller MC
    Endocrinology; 1969 Jan; 84(1):20-7. PubMed ID: 4881999
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmunologic detection and measurement of nonapeptides in the pineal gland.
    Fernstrom JD; Fisher LA; Cusack BM; Gillis MA
    Endocrinology; 1980 Jan; 106(1):243-51. PubMed ID: 7349956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.